Peptide Therapy Costs in 2026: What You'll Actually Pay

Peptide therapy spans a wide price range — from roughly $100 per month for tissue-repair compounds to over $1,300 for brand-name GLP-1 weight-loss drugs like Wegovy. Where you land in that range depends almost entirely on which peptide you're using, whether it's FDA-approved or compounded, and whether insurance or coupon programs offset the sticker price.

GLP-1 and Metabolic Peptides: The High-Cost Tier

Brand-name GLP-1 drugs occupy the most expensive category. Wegovy (semaglutide 2.4 mg weekly) carries a list price around $1,349–$1,788 per month, while Zepbound (tirzepatide, the GLP-1/GIP dual agonist tested in SURMOUNT-1 and published in NEJM) runs approximately $1,060 at wholesale. Those list prices are rarely what patients pay. GoodRx-partnered cash-pay programs brought oral Wegovy tablets to $149/month for the two lowest doses in early 2026, with higher doses settling around $199–$399. Compounded semaglutide and generic tirzepatide from 503A/503B pharmacies typically cost $150–$350 per month — a significant discount, though the FDA's shortage-based authorization for compounding remains subject to change.

The efficacy data justify the premium if you can access coverage: STEP-1 (NEJM) showed semaglutide producing ~14.9% mean body-weight loss vs. 2.4% for placebo, and SURMOUNT-1 showed tirzepatide 15 mg delivering ~20.9% loss at 72 weeks. Those aren't incremental results. For a comparison of how these two agents stack up on cost and outcomes, see our tirzepatide vs. semaglutide breakdown on the peptide stack guide.

Compounded and Off-Label Peptides: The $150–$400 Middle Ground

Growth hormone-related peptides — sermorelin, CJC-1295/ipamorelin — typically run $150–$400 per month through telehealth compounding pharmacies. Tesamorelin (FDA-approved as Egrifta for HIV lipodystrophy) costs $800–$1,200 at brand-name pricing but drops to $200–$400 in compounded off-label protocols. None of the compounded GH secretagogue combinations carry FDA approval in their current stacked forms, so efficacy claims lean heavily on physiological rationale and user experience rather than phase III data.

Tissue-repair peptides like BPC-157 and TB-500 are the budget tier: $150–$300/month each, or $250–$450 for combined protocols. An 8-week BPC-157 cycle commonly runs $150–$250 total. For a detailed look at how these two compounds compare in practice, the BPC-157 vs. TB-500 protocol guide covers loading phases and observed timelines. Nootropic peptides (Semax, Selank) and cosmetic compounds (GHK-Cu, epithalon) fall in the $75–$300/month range — affordable, but supported by thin human trial evidence [1][7].

If you're evaluating providers, compare vetted peptide therapy clinics and telehealth options before committing to any protocol. Most legitimate programs include lab work and follow-up in the quoted monthly cost; those that don't are usually cheaper upfront and more expensive in aggregate.

What Drives the Price Difference

Three factors dominate peptide pricing: regulatory status, manufacturing overhead, and evidence quality. FDA-approved drugs like Ozempic, Saxenda, and Zepbound carry the cost of phase III trial investment and branded manufacturing — that's reflected in list prices [3][6]. Compounded peptides skip that overhead but also skip the quality controls. Research-grade peptides sold through non-clinical suppliers are cheapest but carry the highest purity and dosing uncertainty [1][7].

Most patients in structured telehealth peptide programs pay $200–$500/month all-in. GLP-1 users with insurance or assistance programs often pay under $200. Without any coverage or coupon, a brand-name metabolic peptide easily exceeds $1,000 monthly [3][6]. For access to a provider that offers transparent compounded peptide pricing, NextGen Peptides is one of the more consistently vetted options in this space. You can also explore the full landscape of advanced peptide therapies to understand what's clinically available before committing to a cost tier.

---

Frequently asked questions

How much does peptide therapy cost per month in 2026?

Peptide therapy costs between $100 and $1,788 per month in 2026, depending on the specific compound, its regulatory status, and whether you're using brand-name or compounded versions [1][3]. Most patients on non-GLP-1 compounded protocols — GH secretagogues, tissue-repair peptides, or nootropics — spend $150–$400 monthly. Brand-name GLP-1 drugs like Wegovy and Zepbound carry list prices over $1,000, though cash-pay and coupon programs can reduce effective cost to $149–$399 for many patients.

Are compounded peptides cheaper than brand-name versions?

Yes, compounded peptides are substantially cheaper than their brand-name counterparts, often by 60–80%. Compounded semaglutide from a 503A pharmacy typically costs $150–$350/month versus $1,349+ for Wegovy; compounded tesamorelin runs $200–$400 versus $800–$1,200 for branded Egrifta [1][3]. The tradeoff is reduced